Aller au contenu principal
CAS 0 fiche

CAS 107-97-1

Le CAS 107-97-1 correspond à 0 fiche d’annexe de l’UE dans les annexes II à VI du règlement (CE) n° 1223/2009.

Fiches pour le CAS 107-97-1

0 au total
Aucune fiche trouvée pour ce numéro CAS.

Identité et propriétés chimiques

Structure chimique 2D PubChem pour le CAS 107-97-1
CAS 107-97-1PubChem CID 1088

Sarcosine

Sarcosine is a N-alkylglycine that is the N-methyl derivative of glycine. It is an intermediate in the metabolic pathway of glycine. It has a role as a glycine transporter 1 inhibitor, a glycine receptor agonist, a mouse metabolite, an Escherichia coli metabolite and a human metabolite. It is a N-methyl-amino acid, a member of N-methylglycines and a N-alkylglycine. It is a conjugate base of a sarcosinium. It is a conjugate acid of a sarcosinate. It is a tautomer of a sarcosine zwitterion. — ChEBI

Nom IUPAC
2-(methylamino)acetic acid
Formule moléculaire
C3H7NO2
Masse moléculaire
89.09 g/mol
Masse exacte
89.047678466 Da
XLogP3
-2,8
Surface polaire topologique
49,3 Ų
Donneurs de liaisons hydrogène
2
Accepteurs de liaisons hydrogène
3
Unités covalentes
1
Stéréocentres définis
0

Également connu sous le nom de

N-methylglycineSarcosinic acidMethylglycineGlycine, N-methyl-N-Methylaminoacetic acidMethylaminoacetic acid(Methylamino)acetic acidSarcosin
16 autres noms signalés
(Methylamino)ethanoic acidAcetic acid, (methylamino)-(methylamino)acetateCHEBI:15611Methylaminoethanoic acidZ711V88R5FN MethylglycineSarcosylate, MagnesiumMETHYL GLYCOCOLLRefChem:181358203-538-62-(methylazaniumyl)acetateSargosine hydrochlorideN-Methyl glycineN-MethylglycocollN-methyl-Glycine
Identifiants de bases de données externes

Preuves issues de bases de données scientifiques complémentaires

EMBL-EBI ChEBI
Correspondance exacte d’identifiantCHEBI:15611

sarcosine

A N-alkylglycine that is the N-methyl derivative of glycine. It is an intermediate in the metabolic pathway of glycine.

Formule
C3H7NO2
Masse moyenne
89.094 g/mol
Masse monoisotopique
89.04768 Da
Charge formelle
0
  • N-methylglycines — is a (CHEBI:21766)
  • N-alkylglycine — is a (CHEBI:66933)
  • N-methyl-amino acid — is a (CHEBI:21760)
  • Escherichia coli metabolite — has role (CHEBI:76971)
  • antipsychotic agent — has role (CHEBI:35476)
  • antidepressant — has role (CHEBI:35469)
  • human metabolite — has role (CHEBI:77746)
  • glycine transporter 1 inhibitor — has role (CHEBI:64588)
  • glycine receptor agonist — has role (CHEBI:64589)
  • mouse metabolite — has role (CHEBI:75771)
  • Escherichia coli metabolite — has role (CHEBI:76971)
  • antipsychotic agent — has role (CHEBI:35476)
  • antidepressant — has role (CHEBI:35469)
  • human metabolite — has role (CHEBI:77746)
  • glycine transporter 1 inhibitor — has role (CHEBI:64588)
  • glycine receptor agonist — has role (CHEBI:64589)
  • mouse metabolite — has role (CHEBI:75771)
  • N-methylglycines — is a (CHEBI:21766)
  • N-alkylglycine — is a (CHEBI:66933)
  • N-methyl-amino acid — is a (CHEBI:21760)
  • sarcosinate — is conjugate acid of (CHEBI:46915)
  • sarcosinium — is conjugate base of (CHEBI:46842)
  • sarcosine zwitterion — is tautomer of (CHEBI:57433)
Noms supplémentaires validés
sarcosineN-methylaminoacetic acidL-sarcosineMeGly(methylamino)acetic acidmethylaminoacetic acidMethylamino-acetic acid(methylamino)ethanoic acidN-MethylglycineSarSarcosineSARCOSINEsarcosinic acid
Références croisées de cette source
  • CAS: 107-97-1 — KEGG COMPOUND
  • CAS: 107-97-1 — ChemIDplus
  • CAS: 107-97-1 — NIST Chemistry WebBook
  • REGISTRY_NUMBER: 1699442 — Reaxys
  • REGISTRY_NUMBER: 2018 — Gmelin
  • MANUAL_X_REF: C00213 — KEGG COMPOUND
  • MANUAL_X_REF: c0135 — UM-BBD
  • MANUAL_X_REF: HMDB0000271 — HMDB
  • MANUAL_X_REF: SAR — PDBeChem
  • MANUAL_X_REF: Sarcosine — Wikipedia
  • MANUAL_X_REF: SARCOSINE — MetaCyc

Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Source mise à jour le: 2016-01-27. Récupéré le: 2026-08-31. Ouvrir la fiche source

NIH PubChem PUG-View
Correspondance exacte d’identifiant1088

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou Source: CAMEO Chemicals
  • Note: This chemical does not meet GHS hazard criteria for 98.7% (149 of 151) of all reports. Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: Not Classified; Reported as not meeting GHS hazard criteria by 149 of 151 companies (only 1.3% companies provided GHS information). For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 151 reports by companies from 3 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 149 of 151 reports by companies.; There is 1 notification provided by 2 of 151 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Health Effects: Acyl sarcosines may cause irritation to the skin and eyes. They may also react to produce N-nitrososarcosine, which is believed to be carcinogenic. (A2881) Source: Toxin and Toxin Target Database (T3DB)
  • Health Effects: Acute Exposure: Can lead to eye and skin irritation. Chronic Exposure: High levels of sarcosine in prostate tissues are associated with aggressive prostate tumors. In this regard, sarcosine appears to function as an oncometabolite. High levels of sarcosine are also seen in patients with sarcosinemia. Sarcosinemia is a rare inborn error of metabolism that is characterized by an increased level of sarcosine (N-methylglycine) in the plasma and urine. The enzymatic block results from a deficiency of sarcosine dehydrogenase (SarDH), a liver mitochondrial matrix enzyme that converts sarcosine into glycine. The disease is mostly characterized by mental delay, cardiomyopathy, deafness and visual disturbance. Source: Toxin and Toxin Target Database (T3DB)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that the following ingredients are safe as used in cosmetics when formulated to be non-irritating. The Expert Panel cautions that these ingredients should not be used in cosmetic products in which N-nitroso compounds can be found...Cocoyl Sarcosine... Source: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications Source: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: While acyl sarcosines themselves are not toxic, they are nitrosating agents. Nitrosating agents may decompose and/or react to cause nitrosamine contamination. Nitrosamines are produced from secondary amines and amides in the presence of nitrite ions and are believed to be carcinogenic. The particular nitrosamine produced by acyl sarcosines is N-nitrososarcosine. Once in the body, nitrosamines are activated by cytochrome P-450 enzymes. They are then believed to induce their carcinogenic effects by forming DNA adducts at the N- and O-atoms. (L1889, L1890, A2878, A2879, A2880, A2881) Source: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: Sarcosine is an oncometabolite. Sarcosine appears to upregulate the expression of the potent oncoprotein called human epidermal growth factor receptor 2 (HER2/neu) in androgen-dependent prostate cancer cells upon exposure to exogenous sarcosine. Thus, sarcosine may induce prostate cancer progression by increased HER2/neu expression. Source: Toxin and Toxin Target Database (T3DB)
  • Cosmetic Ingredient Review Link: CIR ingredient: Cocoyl Sarcosine Source: Cosmetic Ingredient Review (CIR)
  • Sources/Uses: Used as an intermediate in synthesis of toothpaste antienzyme agents; [Merck Index] An amino acid intermediate in the metabolism of choline. [ChemIDplus] Used to make antienzyme agents for cosmetics and pharmaceuticals; [NTP] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: Acyl sarcosines are used as hair-conditioning agents and surfactant-cleansing agents in cosmetics, as well as to improve wetting and penetration of topical pharmaceutical products. Acyl sarcosines and their sodium salts are also used in the metal finishing and processing industries for their crystal modifying, anti-rust, and anti-corrosion properties. (A2881) Source: Toxin and Toxin Target Database (T3DB)
  • Uses: Sarcosine can be used as a cognitive enhancer and to treat schizophrenia. Source: Toxin and Toxin Target Database (T3DB)

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
EMBL-EBI ChEBICorrespondance exacte2026-08-31
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Comment le CAS 107-97-1 est utilisé sur ce site

Le CAS 107-97-1 est l’identifiant du Chemical Abstracts Service utilisé pour rattacher cette page à une substance précise. Dans le jeu de données actuel, 0 fiche d’annexe de l’UE partage cet identifiant, ce qui vous aide à vérifier si la même substance apparaît dans un seul contexte réglementaire ou dans plusieurs.

Utilisez cette page lorsqu’une spécification fournisseur, une FDS ou un dossier de matière première vous donne le CAS 107-97-1 et que vous devez voir au même endroit toutes les fiches liées des annexes II à VI. Les cartes d’entrées ci-dessus sont le moyen le plus rapide d’accéder aux limites de concentration, aux avertissements, à l’annexe concernée et aux conditions par type de produit.